Jun-Gyu Park

Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus.

Structural basis of RNA cap modification by SARS-CoV-2.

Identification of Inhibitors of ZIKV Replication.

Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.

Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.

Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.

Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters.

Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2.

FACT subunit SUPT16H associates with BRD4 and contributes to silencing of antiviral interferon signaling.

Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents.

Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2.

Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses.

The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus.